This is a preprint.
Autistic traits in myotonic dystrophy type 1 due to MBNL inhibition and RNA mis-splicing
- PMID: 37645891
- PMCID: PMC10462192
- DOI: 10.21203/rs.3.rs-3221704/v1
Autistic traits in myotonic dystrophy type 1 due to MBNL inhibition and RNA mis-splicing
Update in
-
Autism-related traits in myotonic dystrophy type 1 model mice are due to MBNL sequestration and RNA mis-splicing of autism-risk genes.Nat Neurosci. 2025 Jun;28(6):1199-1212. doi: 10.1038/s41593-025-01943-0. Epub 2025 Apr 21. Nat Neurosci. 2025. PMID: 40259070 Free PMC article.
Abstract
Tandem repeat expansions are enriched in autism spectrum disorder, including CTG expansion in the DMPK gene that underlines myotonic muscular dystrophy type 1. Although the clinical connection of autism to myotonic dystrophy is corroborated, the molecular links remained unknown. Here, we show a mechanistic path of autism via repeat expansion in myotonic dystrophy. We found that inhibition of muscleblind-like (MBNL) splicing factors by expanded CUG RNAs alerts the splicing of autism-risk genes during brain development especially a class of autism-relevant microexons. To provide in vivo evidence that the CTG expansion and MBNL inhibition axis leads to the presentation of autistic traits, we demonstrate that CTG expansion and MBNL-null mouse models recapitulate autism-relevant mis-splicing profiles and demonstrate social deficits. Our findings indicate that DMPK CTG expansion-associated autism arises from developmental mis-splicing. Understanding this pathomechanistic connection provides an opportunity for greater in-depth investigations of mechanistic threads in autism.
Keywords: ANK2; ASD; DMPK; MBNL; SRRM4; alternative splicing; autism spectrum disorder; microexon; myotonic dystrophy; short tandem repeat expansion.
Conflict of interest statement
Declaration of interests M.S.S. is a Scientific Advisory Board member for Skyhawk Therapeutics and Tacit Therapeutics. Other authors declare no competing interests.
Figures







References
-
- Soke G.N., Maenner M.J., Christensen D., Kurzius-Spencer M. & Schieve L.A. Prevalence of Co-occurring Medical and Behavioral Conditions/Symptoms Among 4- and 8-Year-Old Children with Autism Spectrum Disorder in Selected Areas of the United States in 2010. J Autism Dev Disord 48, 2663–2676 (2018). - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources